Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial
Authors:
- 1 February 2017
- journal article
- retracted article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 31 (3) , 388-394
Abstract
Objective: The current study aims to evaluate the effect of peri-conceptional progesterone started early in the luteal phase before confirmation of pregnancy in preventing miscarriage in women with history of unexplained recurrent miscarriage (RM).Materials and methods: The current study was a randomized double-blind controlled trial (NCT01608347) conducted at Assiut Women's Health Hospital from 2012 through 2015 included patients of unexplained RM. Participants were randomly assigned to receive either 400mg progesterone pessaries or placebo twice daily, started in the luteal phase and continued after a positive pregnancy test till 28weeks of gestation. The main study outcome was the miscarriage rate.Results: Seven hundred women were enrolled (n=350 in each group). The miscarriage rate was significantly lower in progesterone group (12.4 versus 23.3% in the placebo group, p=0.001). There was significant improvement in rate of pregnancy continuation beyond 20weeks as well as the live birth rate in the progesterone group in comparison to placebo group (87.6 versus 76.7% and 91.6 versus 77.4%, respectively, p<0.05).Conclusions: Progesterone is more effective than placebo in reducing the risk of miscarriage if administered in the luteal phase of the cycle, before confirmation of pregnancy in women with history of unexplained RM.Keywords
This publication has 21 references indexed in Scilit:
- A comparative study of dydrogesterone and micronized progesterone for luteal phase support duringin vitrofertilization (IVF) cyclesGynecological Endocrinology, 2015
- Incidence and risk factors for recurrent spontaneous preterm birth: A retrospective cohort study in JapanJournal of Obstetrics and Gynaecology Research, 2015
- RETRACTED: Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trialFertility and Sterility, 2014
- Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages?BMJ, 2011
- Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trialUltrasound in Obstetrics & Gynecology, 2011
- Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesteroneJournal of Endocrinology, 2007
- Management of recurrent miscarriage: evaluating the impact of a guidelineHuman Reproduction, 2007
- Recurrent miscarriageThe Lancet, 2006
- Age-specific risk of fetal loss observed in a second trimester serum screening populationAmerican Journal of Obstetrics and Gynecology, 2005
- Recurrent miscarriage I: definition and epidemiologyThe Lancet, 1990